Immunome (IMNM) Market Capitalization (2020 - 2026)
Immunome (IMNM) reported Market Capitalization of $2.4 billion for Q2 2026, up 196.9% from $809.22 million a year earlier but down 2.9% from the prior quarter.
Powered by 
Analysis
Immunome (IMNM) Market Capitalization (2020 - 2026) Analysis & Trends
For FY2025, Immunome posted Market Capitalization of $1.88 billion, up 174.1% from FY2024.
- Market Capitalization has increased for three consecutive years, with a five-year compound annual growth rate of 124.6% (FY2020 to FY2025).
- By year, Market Capitalization came in at $684.57 million in FY2024 (+222.4%), $212.33 million in FY2023 (+692.1%), $26.8 million in FY2022 (-82.9%) and $156.95 million in FY2021 (+378.3%).
- Five-year quarterly Market Capitalization spans a low of $26.8 million in Q4 2022 and a high of $2.48 billion in Q1 2026.
- Year over year, Market Capitalization has now increased in each of the last five quarters, with growth averaging 207.0% over the last eight quarters.
- The high point for year-over-year Market Capitalization in five years was Q3 2024 (growth of 767.0%); the low point was Q4 2022 (a decline of 82.9%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $2.48 billion (Q1 2026), $1.88 billion (Q4 2025) and $1.07 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn |
| 10 | Immunome | 2.48 Bn | 453.48 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.40 Bn |
| Mar 31, 2026 | 2.48 Bn |
| Dec 31, 2025 | 1.88 Bn |
| Sep 30, 2025 | 1.07 Bn |
| Jun 30, 2025 | 809.22 Mn |
| Mar 31, 2025 | 585.21 Mn |
| Dec 31, 2024 | 684.57 Mn |
| Sep 30, 2024 | 883.37 Mn |
| Jun 30, 2024 | 726.17 Mn |
| Mar 31, 2024 | 1.47 Bn |
| Dec 31, 2023 | 212.33 Mn |
| Sep 30, 2023 | 101.89 Mn |
| Jun 30, 2023 | 96.51 Mn |
| Mar 31, 2023 | 60.85 Mn |
| Dec 31, 2022 | 26.80 Mn |
| Sep 30, 2022 | 53.85 Mn |
| Jun 30, 2022 | 38.93 Mn |
| Mar 31, 2022 | 68.88 Mn |
| Dec 31, 2021 | 156.95 Mn |
| Sep 30, 2021 | 294.47 Mn |
API Access
Immunome Market Capitalization API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=market-capitalization&ticker=IMNM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "market-capitalization", "ticker": "IMNM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=market-capitalization&ticker=IMNM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();